RxDoctor Payments Data

Kevin Penn

General Practice · Seattle, WANPI 1558773937

Payments from drug & device makers

$5,144in general payments, 2019–2025

Across 12 payments — averaging $428.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$5K
  • Solventum Corporation$104

What the payments were for

  • Consulting fees$5,04098%
  • Food & beverage$1042%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis10$5,040
Solventum Corporation2$104

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,144 in reported general payments places this provider in the 95th percentile of 2,229 general practice providers in Washington.

See all general practice providers in Washington

Medicare billing

Part B allowed, 2024
$379,370
Medicare patients
369
Services billed
3,696

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other general practice in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →